Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide for brain metastasis prophylaxis in breast cancer
NCT00638963Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Oct 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of temozolomide in breast cancer, sponsored by Merck & Co.. Started Oct 2008; status: terminated.
02
Drugs
temozolomide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00638963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00638963.